Allarity Therapeutics, Inc. Gain (Loss) Recognized on Assets Transferred to Separate Account
Allarity Therapeutics, Inc. (ALLR) reported Gain (Loss) Recognized on Assets Transferred to Separate Account of $96.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-10-07.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRecognizedOnAssetsTransferredToSeparateAccount · last filed 2023-05-11
- Allarity Therapeutics, Inc. gain (loss) recognized on assets transferred to separate account for the quarter ending 2022-06-30 was $95.96K.
- Allarity Therapeutics, Inc. gain (loss) recognized on assets transferred to separate account for the quarter ending 2022-03-31 was $36.00.
| Period end | Gain (Loss) Recognized on Assets Transferred to Separate Account 3 month | Gain (Loss) Recognized on Assets Transferred to Separate Account 6 month |
|---|---|---|
| 2022-06-30 | $95.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | $96.00K 10-Q · filed 2022-10-07 |
| 2022-03-31 | $36.00 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $180.00K 10-Q · filed 2022-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |